We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Maura Dickler

Maura Dickler MD

Associate Attending Physician, Memorial Sloan-Kettering Cancer Center; Assistant Professor of Medicine, Weill Medical College of Cornell University

Dr. Maura N. Dickler received her medical degree from the Pritzker School of Medicine at the University of Chicago in Chicago, Illinois. She completed her internship and residency at the University of Chicago Hospitals, followed by a fellowship in hematology and medical oncology at Memorial Sloan-Kettering Cancer Center in New York. Dr. Dickler is board certified in internal medicine and medical oncology.

Dr. Dickler’s clinical research focuses on developing new therapeutic approaches for the treatment of breast cancer and investigating the impact of these therapies on fertility and sexual health. Her studies involve the investigation of therapies that interfere with estrogen in women who have hormone-receptor−positive breast cancer. In addition, she has studied targeted therapies for other growth-factor−signaling pathways, especially those targeting EGFR, VEGF, PI3K, and HER2. Use of these therapies in combination (eg, antiestrogen plus antiangiogenic therapy) is a focus of her work. Other clinical research involves trials evaluating the effects of breast cancer therapy on ovarian reserve in premenopausal women and the use of intravaginal estrogen and other non-hormonal therapies to ameliorate vaginal dryness in postmenopausal women.

Dr. Dickler is a member of the New York Metropolitan Breast Cancer Group, the American Society of Clinical Oncology (ASCO), and the American College of Physicians/American Society of Internal Medicine, among other professional organizations. She also serves on the National Cancer Institute−sponsored Alliance Breast Committee, the Endocrine-Related Cancer Journal Editorial Board, and has been a prior member of the ASCO Breast Cancer Education Committee.

Dr. Dickler has contributed peer-reviewed articles, review articles, book chapters, and abstracts to the medical literature in her field. She is an ad hoc reviewer for several clinical journals, including The Lancet, The New England Journal of Medicine, the Journal of Clinical Oncology, Clinical Cancer Research, and Breast Cancer Research and Treatment.

Positions:
Associate Attending Physician
Memorial Sloan-Kettering Cancer Center
Weill Medical College of Cornell University, NY

Degrees:
Pritzker School of Medicine, Chicago, Illinois, MD

Postgraduate Training:
Resident, University of Chicago Hospitals, Chicago
Fellow, Memorial Sloan-Kettering Cancer Center, New York

Board Certifications:
Internal Medicine, Medical Oncology

Clinical Interests:
Breast cancer treatment; targeted therapy (estrogen, VEGF, EGFR/HER1, HER2); antiangiogenesis; effect of treatment on fertility and sexual health